Gordon Joseph F's Form 4 filing
Bausch Health Companies Inc. (BHC) · filed Mar 10, 2022
- Accession no.
- 0001127602-22-008873
- Filed
- Mar 10, 2022
- Trade date
- Mar 8, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $84.6K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon Joseph FCIK 0001749876 | Officer (Pres&Co-Head Bausch&Lomb/Int'l) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 8, 2022 | Common Shares, No Par Value | SSaleDisposed | −3,889 | $21.76 | −$84,624.64 | 93,139 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.